vimarsana.com
Home
Live Updates
Following the FDA, EMA also Grants an Orphan Drug Designation of SN Biosciences Nano Anti-Cancer Drug SNB-101 for Small Cell Lung Cancer. : comparemela.com
Following the FDA, EMA also Grants an Orphan Drug Designation of SN Bioscience's Nano Anti-Cancer Drug 'SNB-101' for Small Cell Lung Cancer.
/PRNewswire/ -- SN Bioscience Co., Ltd. (CEO Park Young-hwan) announced on May 24 that European Medicines Agency(EMA) had granted an orphan drug designation...
Related Keywords
South Korea ,
Seoul ,
Soult Ukpyolsi ,
,
Bioscience Inc ,
Prnewswire Sn Bioscience Co Ltd ,
European Medicines Agency ,
Fast Track ,
comparemela.com © 2020. All Rights Reserved.